Oct 21 (Reuters) - Xvivo Perfusion AB XVIVO.ST :
* XVIVO PRESENTS INTERIM REPORT JANUARI-SEPTEMBER 2021
* Q3 NET SALES AMOUNTED TO SEK 54.9 MILLION (42.7),
CORRESPONDING
TO AN INCREASE OF 29 PERCENT IN SEK AND 31 PERCENT IN LOCAL
CURRENCIES.
* Q3 NET SALES OF NON-DURABLE GOODS AMOUNTED TO SEK 48.9
MILLION
(42.3),
* Q3 ADJUSTED OPERATING PROFIT BEFORE DEPRECIATION AND
AMORTIZATION (EBITDA) AMOUNTED TO SEK 5.3 MILLION (9.3)
* Q3 REPORTED EBITDA AMOUNTED TO SEK 4.2 MILLION (-11.2)
Source text for Eikon: ID:nMFN5vWfvf
Further company coverage: XVIVO.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))